If you get some or all of your health coverage through Medicare, but you get your prescription drug benefit through a retirement plan from a previous employer or union, you may not be eligible for GLP-1 drug through Bridge
The US FDA grants accelerated approval to Ascendis Pharmas Yuviwel (Navepegritide) as the first once-weekly CNP therapy for Achondroplasia, with US launch expected in Q2 2026 Subscribe to our weekly newsletter and never miss a beat: #ascendispharma #yuviwel #navepegritide #usfda #acceleratedapproval #achondroplasia #approach #jamapediatrics #rpdprv #regulatory FDA Approves Ascendis Pharma's Yuviwel for Achondroplasia The US FDA grants accelerated approval to Ascendis Pharmas Yuviwel (Navepegritide) as the first once-weekly CNP therapy for Achondroplasia, with US launch expected in Q2 2026 Subscribe to our weekly newsletter and never miss a beat: #ascendispharma #yuviwel #navepegritide #usfda #acceleratedapproval #achondroplasia #approach #jamapediatrics #rpdprv #regulatory To view or add a comment, sign in More Relevant Posts Excited to share our recent publication highlighting Neursantys breakthroughs in balance and mobility restoration in real-world senior living settings -- a practical longevity intervention available today with no complex pharmaceutical development required: To view or add a comment, sign in Zymeworks Inc
Not just weight loss: Complete metabolic transformation for body, energy, mind, and skin
SUPPORTS OVERALL SKIN HEALTH:With the added benefits of 10mg Hyaluronic Acid, this formula not only antioxidant but also deeply hydrates, ensuring your skin remains healthy
